Company / EPS (Basic)
Exelixis EPS (Basic) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.65
FY2025
5-year range
$0.36 / $1.06
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
#37 of 208
Health Care
What the data says
Exelixis's eps (basic) of $0.65 is higher than 82% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 9 years, ranging from $-0.77 in FY2017 to $2.32 in FY2020.
Based on SEC 10-K filings.
0.65 in FY2025 with a 5-year CAGR of -22.5%. Top quartile in the Health Care sector.
Declined from $0.73 to $0.65 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +21.8%
- 5-Year CAGR
- -22.5%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 208This company $0.65 Sector average -$0.96
▼
+167.5% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 14.0% year-over-year.
- Ranks #37 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2020.
- Lowest eps (basic) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | +14.0% |
| FY2024 | $0.57 | -21.9% |
| FY2023 | $0.73 | +102.8% |
| FY2022 | $0.36 | -66.0% |
| FY2021 | $1.06 | -54.3% |
| FY2020 | $2.32 | +346.2% |
| FY2019 | $0.52 | +285.7% |
| FY2018 | -$0.28 | +63.6% |
| FY2017 | -$0.77 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026